CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Sales
Capitation revenue, net	$ 5,386,064	$ 1,594,712
SaaS revenue	333,445	419,633
Management service revenue, net	489,666	0
Total sales	6,209,175	2,014,345
Cost of sales	4,492,930	1,587,473
Gross profit	1,716,245	426,872
Operating expenses
Research and development	73,750	76,720
Sales and marketing	11,055	9,739
General and administrative expenses	17,782,908	4,426,292
Amortization	216,453	64,044
Total operating expenses	18,084,166	4,576,795
Income (loss) from operations	(16,367,921)	(4,149,923)
Other income (expenses)
Income from forgiveness of debt	260,087	0
Interest income	368	114
Interest expense - debt obligations	(186,916)	(334,331)
Interest expense - accretion of debt discount	(283,692)	0
Total other income (expenses)	(210,153)	(334,217)
Loss from operations before income tax benefit	(16,578,074)	(4,484,140)
Income tax benefit - current	8,889	0
Net loss	(16,569,185)	(4,484,140)
Net income attributable to noncontrolling interest	193,856	(39,581)
Net income (loss) attributable to Clinigence Holdings, Inc.	$ (16,763,041)	$ (4,444,559)
Basic and fully diluted income (loss) per common share	$ (0.35)	$ (0.24)
Weighted average common shares outstanding - basic and fully diluted	48,270,427	18,571,298